0.00Open0.00Pre Close0 Volume0 Open Interest90.00Strike Price0.00Turnover0.00%IV-26.34%PremiumSep 20, 2024Expiry Date32.19Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.79Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Lamar Advertising Co Stock Discussion
• $Allegiance (ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge (BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence (CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares (FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co (LAMR.US)$ : Citigroup Up...
• $Cogent Biosciences (COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions (UNVR.US)$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts (MTN.US)$ +6% (In reaction to earnings/guidance)
• $BeiGene (BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
• $CME Group (CME.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $235
• $Spirit Airlines (SAVE.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $30 (from $24)
• $SciPlay (SCPL.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $14.50)
Downgrades
• $Bilibili (BILI.US)$ : ICBC Downgrades to Neutral from Outperform - PT $26.20
• $Blueprint Medicines (BPMC.US)$ : Citigroup Downgrades to Se...
No comment yet